USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Videos
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
80 y/o Male With Immune Complex-Mediated Tubulointerstitial Nephritis, Seronegative Inflammatory Arthritis, and Severe Polyarticular Joint Pain: Why It's Important to Question Seronegative Inflammatory Arthritis? How Important Is Arthrocentesis?
FEATURING
Lauren Mathias
- 312 views
- November 26, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Calcium Crystal Deposition in Gout: What Is the Impact of CCP, and BCP Crystals in Acute CCP Crystal Arthritis? What Are the Current Therapies for CPPD?
FEATURING
Sky Wang
- 721 views
- November 24, 2020
- 4
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Sjogren's Syndrome Diagnosis: What Are the Testing Methodologies, and Diagnosis Criteria? What Is the Importance of Additional Criteria Not Outlined by ACR or EULAR?
FEATURING
Jenny Jun
- 320 views
- November 24, 2020
- 3
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Update on Sjogren's Syndrome: How to Manage Sicca, and Extraglandular Symptoms Through Topical NSAIDs, Corticosteroids, and Immunosuppressants?
FEATURING
Jenny Jun
- 684 views
- November 24, 2020
- 10
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Ocular Toxicity of Rheumatologic Drugs: What Is the Role and Effects of Traditional DMARDs, Biologic DMARDs, Chloroquine and Hydroxychloroquine on Ocular Health?
FEATURING
Linda Lam
- 155 views
- November 24, 2020
- 2
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Update on SLE Classification: What Are New SLICC, EULAR, and ACR Items and Definitions? What Is the Goal of Specificity, and the Importance of Immunology?
FEATURING
Stavros Savvas
- 187 views
- November 24, 2020
- 2
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Emerging Therapeutics in SLE: What Is the Impact and Efficacy of Anifrolumab, Ustekinumab, Baricitinib, and the New JAK Inhibitors?
FEATURING
Stavros Savvas
- 370 views
- November 24, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID-19 Outcomes? Are Patients With APL Antibodies at Higher Risk for Thrombotic Events?
FEATURING
Leanna Wise
- 670 views
- November 24, 2020
- 4
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving Efficacy in Recovery? What Are the Current ACR Recommendations for COVID-19 Positive and Negative Patients?
FEATURING
Leanna Wise
- 372 views
- November 24, 2020
- 3
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Skin Manifestations of COVID-19: What Are the Most Common Patterns of Injury and How to Treat Them? Are Skin Manifestations of COVID-19 Heterogeneous? Can They Be Life-Threatening?
FEATURING
Binh Ngo
- 387 views
- November 11, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Use of Cannibis in Rheumatology: What Are the Effects and Efficacy for Use in Fibromyalgia, RA, SLE, AS, FMF, Crohn's, Systemic Sclerosis, and Osteoarthritis?
FEATURING
Samy Metyas
- 4,060 views
- November 11, 2020
- 24
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Medical Marijuana and CBD in Rheumatology: How Effective Is for Chronic Pain and Inflammation? What Are the Cannabis Pharmacological (CNS) Effects, and FDA Approved Medication?
FEATURING
Samy Metyas
- 918 views
- November 11, 2020
- 8
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
New Treatment Approaches for Psoriasis: What Are the AAD Management Recommendations? What Is the Efficacy of Topical Agents, Phototherapy, and Systemic Agents?
FEATURING
Binh Ngo
- 675 views
- November 11, 2020
- 6
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
axSpA Treatment Update: What Is the Response Rate, Proper Use and Efficacy of Specific NSAIDS, csDMARDs, TNF Inhibitors and JAK Inhibitors?
FEATURING
Daniel Arkfeld
- 1,743 views
- November 11, 2020
- 6
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Imaging in RA and axSpA: What Can Be Seen in Plain Imaging, Ultrasounds, MRI and Retroadvanced Imaging? What Does the Future Hold for OA Imaging, PET/CT Scans and AI for Early Detection of Arthritic Conditions?
FEATURING
Stratos Christianakis
- 627 views
- November 11, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
RA and Biologic Therapies Update: Where Do Products Fit on the RA Spectrum of Treatment? What Are Specifics on TNF Inhibitors, Il-1, Il-6 Receptor Blockers and CD20 Antigens on Lymphocytes?
FEATURING
Glenn Ehresmann
- 491 views
- November 11, 2020
- 4
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
DMARDS Biologic in RA: What Are Safety Issues and Concerns? What Are the Malignancy, and Immune Disease Risks Induced by Biologics?
FEATURING
Glenn Ehresmann
- 300 views
- November 11, 2020
- 3
